Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of Petros Pharmaceuticals, Inc. and Subsidiaries (the “Company”) on Form S1 to be filed on or about January 24, 2025 of our report dated March 31, 2023, on our audit of the consolidated financial statements as of December 31, 2022 and for the year then ended. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
January 24, 2025
